TY  - JOUR
AU  - Villanego, Florentino
AU  - Mazuecos, Auxiliadora
AU  - Cubillo, Beatriz
AU  - Merino, M José
AU  - Poveda, Inmaculada
AU  - Saura, Isabel M
AU  - Segurado, Óscar
AU  - Cruzado, Leónidas
AU  - Eady, Myriam
AU  - Zárraga, Sofía
AU  - Aladrén, M José
AU  - Cabello, Sheila
AU  - López, Verónica
AU  - González, Esther
AU  - Lorenzo, Inmaculada
AU  - Espí-Reig, Jordi
AU  - Fernández, Constantino
AU  - Osma, July
AU  - Ruiz-Fuentes, M Carmen
AU  - Toapanta, Néstor
AU  - Franco, Antonio
AU  - Burballa, Carla C
AU  - Muñoz, Miguel A
AU  - Crespo, Marta
AU  - Pascual, Julio
PY  - 2022
DO  - 10.1093/ckj/sfac177
SN  - 2048-8505
UR  - http://hdl.handle.net/10668/19754
T2  - Clinical kidney journal
AB  - Sotrovimab is a neutralizing monoclonal antibody (mAb) that seems to remain active against recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. The evidence on its use in kidney transplant (KT) recipients, however, is limited....
LA  - en
KW  - COVID-19
KW  - immunosuppression
KW  - kidney transplantation
KW  - monoclonal antibodies
KW  - mortality
TI  - Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients.
TY  - research article
VL  - 15
ER  -